New Approaches: Novel Receptor Science in Schizophrenia

Registration Options

Activity Dates: 06/01/2023 - 05/31/2024

Session Summary

New treatments for schizophrenia are just around the corner and their pharmacological properties bring into question the etiology of schizophrenia. Novel antipsychotic therapies without D2 receptor activity have significant implications for care, and if approved, will represent the "third-generation" of antipsychotic medications. Join Dr. Jonathan Meyer for a compelling symposium that will cover these recent advancements in our understanding of schizophrenia and how novel pharmacotherapies that act upstream of the dopamine receptors may prove effective at addressing current treatment limitations.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

Sign in (or create a FREE account).
Register for this course.
Review the full content of the activity and reflect upon its teachings.
Complete the post-test at the end of the activity no later than the closing activity date.
Complete the evaluation at the end of the activity.
If necessary, complete the post-test retest no later than the closing activity date.
Receive a passing grade (70%).
Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Your ACPE credit will be submitted directly to CPE Monitor within 48 hours of successful completion of the exam and of the evaluation form if you have provided the relevant information in your profile.

View System Requirements to Access All Session Resources

AAPP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access AAPP course materials online, you will need:

A modern web browser with JavaScript and cookies enabled: Chrome is strongly recommended, or the latest version of Firefox or Safari.
A PDF reader: Chrome built-in, Firefox built-in, Acrobat or FoxIt
An adequate device and Internet connection: Processor: Dual-core 2Ghz or higher (Intel i3/i5/i7 or AMD equivalent); Memory: 4 GB; Storage: 5 GB available; Internet speed: 4.0 Mbps (up/down)

AAPP web sites no longer fully support Microsoft Internet Explorer or Windows 8.1 and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.

Faculty Information and Disclosures

Jonathan M. Meyer, MD

View biographical information and disclosures

Learning Objectives

Explore the evolving understanding of the neurobiology of schizophrenia.
Differentiate the mechanisms of action of in-development treatments for schizophrenia.
Implement novel treatments for schizophrenia into clinical practice as they become available to address residual symptoms, medication side effects, and treatment nonadherence.

Continuing Education Credit and Disclosures

Activity Dates: 06/01/2023 - 05/31/2024
ACPE Contact Hours: 1
ACPE Number: 0284-9999-23-047-H01-P
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPE The American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.

Grant Support

This activity is supported by an unrestricted educational grant from Sunovion and Otsuka America Pharmaceutical, Inc.